Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fireworks Kept At Bay As Congress Pushes To Enact FDA Reforms By July 4

This article was originally published in The Gray Sheet

Executive Summary

Bipartisan FDA user fee reauthorization and reform legislation sailed unanimously through the House Energy and Commerce Committee May 10, with many similarities to a Senate version that has also passed out of committee.

Advertisement

Related Content

Congress Enters Final Stages On FDA Reform Bill
FDA User Fee Reauthorization Charges Along With Senate Passage
House Moves Closer To Senate On FDA Bill
Senate Committee Moves Bipartisan FDA Reform Bill Toward Floor
CDRH Plans To Redraft Maligned 510(k) Modifications Proposal
Senate Plans FDA User Fee Markup This Week; House Not Far Behind
Senate Draft Bill Compromises On Profit Incentive For Humanitarian Devices
Device Industry Expects Quicker Path To Market In Exchange For Doubling Of User Fees
Markey Bill Would Bar 510(k) Clearances Of Devices With Recalled Predicates
FDA Begins Review Of Pre-amendments Device Data Submissions

Topics

Advertisement
UsernamePublicRestriction

Register

MT031216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel